Health
$160,000 drug for multiple myeloma blood cancer added to PBS at a cost to patients of $480 – The New Daily
More than 1000 patients with an incurable blood cancer are expected to benefit from a “completely new” treatment subsidised by the federal government.
More than 1000 patients with an incurable type of blood cancer are expected to benefit from a “completely new” treatment that will be subsidised by the federal government in the new year.
Darzalex, which will be listed on the Pharmaceutical Benefits Scheme (PBS) from January 1, is a medicine used to treat multiple myeloma, a cancer that causes cancerous plasma cells to accumulate in bone marrow and crowd out healthy blood cells.
An estimated 18,000 to 20,000 people are living with multiple myeloma…
-
Noosa News23 hours agoFirst home buyers’ options to almost double under expanded Home Guarantee Scheme
-
Noosa News24 hours agoSun Spirit sculpture returns ahead of Swell Sculpture Festival
-
Business23 hours ago3 ASX 200 gold stocks just upgraded to buy ratings
-
Noosa News21 hours agoBrisbane crowned Australia’s top sports city; Back to the future on water taxis for the Brisbane River; Schoolies safety push after methanol poisoning